Evidence map›Paper›PMID 42775263›Full record

ArticleFrontiers in surgery2026

One patient with synchronous multiple primary colon cancers which is easy to miss: a case report.

Xinmin Bao, Haoru Liu, Ming Wu, Xianwei Liu

Abstract readCase Reports
In one paragraph

Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xinmin BaoDepartment of General Surgery, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi, China.
Haoru LiuDepartment of Pathology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi, China.
Ming WuDepartment of Image Center, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi, China.
Xianwei LiuDepartment of General Surgery, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple primary colon cancer is a relatively rare type of colon cancer (CC), and it is even rarer to have endoscopic obstruction. Case summary: A 70-year-old female patient was previously diagnosed with sigmoid colon cancer accompanied by endoscopic obstruction at an external hospital. Preoperative abdominal enhanced CT in our hospital revealed one segmental bowel wall thickening with intussusception, and two separate thickened lesions in the transverse colon. During the operation, it was found that the intestinal wall of sigmoid colon, the transverse colon near splenic flexure and the ascending colon were obviously thickened and stiff, and the lymph nodes at the root of inferior mesenteric artery, the ileocolic artery and middle colon artery were swollen. Finally, we performed laparoscopic sigmoidectomy, left hemicolectomy, and right hemicolectomy with mesenteric lymph node dissection and ileorectal anastomosis. Postoperative pathological examination confirmed that adenocarcinoma existed in sigmoid colon, transverse colon and ascending colon. Conclusion: Intraoperative comprehensive exploration is critical for the management of obstructive colon cancer. For patients with incomplete preoperative colonoscopy caused by tumor-induced luminal obstruction, meticulous intraoperative assessment is essential to avoid missed diagnosis of synchronous multiple CC and optimize long-term oncological outcomes.

Indexed as

CTendoscopic obstructionmissed diagnosismultiple primary colon canceroperation

Identifiers

PMID42775263
PMCPMC13596035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.